Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	malate dehydrogenase (decarboxylating) (NADP+) activity	ME1 ME2 ME3	8.35e-07	3	189	3	GO:0004473
GeneOntologyMolecularFunction	malic enzyme activity	ME1 ME2 ME3	3.32e-06	4	189	3	GO:0004470
GeneOntologyMolecularFunction	oxaloacetate decarboxylase activity	ME1 ME2 ME3	3.32e-06	4	189	3	GO:0008948
GeneOntologyMolecularFunction	malate dehydrogenase activity	ME1 ME2 ME3	4.51e-05	8	189	3	GO:0016615
GeneOntologyMolecularFunction	tau-protein kinase activity	MARK1 BRSK2 SIK3 BRSK1	4.98e-05	22	189	4	GO:0050321
GeneOntologyMolecularFunction	malate dehydrogenase (decarboxylating) (NAD+) activity	ME1 ME2	8.91e-05	2	189	2	GO:0004471
GeneOntologyMolecularFunction	phosphatidylinositol phosphate binding	FGD2 MARK1 MYO1B VPS36 PLA2G4E PLEKHN1 ZFYVE1 SH3PXD2B ARAP1	1.21e-04	199	189	9	GO:1901981
GeneOntologyMolecularFunction	carbon-carbon lyase activity	ME1 ME2 ME3 PISD MOCS1	1.86e-04	56	189	5	GO:0016830
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	EPHB3 MPP1 ABL2 MARK1 SPEG POLR2B BRSK2 POLRMT OAS3 SIK3 MAPKAPK5 PTK2 GRK3 PI4KB NRK MYLK4 ALPK3 TJP2 PRKCQ BRSK1 NME3	2.28e-04	938	189	21	GO:0016772
GeneOntologyMolecularFunction	phospholipid binding	ABCA1 CARMIL2 FGD2 MARK1 GAS6 MYO1B APOB VPS36 PLA2G4E PLEKHN1 ZFYVE1 BDH1 F10 SH3PXD2B ARAP1	2.36e-04	548	189	15	GO:0005543
GeneOntologyMolecularFunction	kinase activity	EPHB3 MPP1 ABL2 MARK1 SPEG BRSK2 SIK3 MAPKAPK5 PTK2 GRK3 PI4KB NRK MYLK4 ALPK3 TJP2 PRKCQ BRSK1 NME3	3.57e-04	764	189	18	GO:0016301
GeneOntologyMolecularFunction	carboxy-lyase activity	ME1 ME2 ME3 PISD	3.61e-04	36	189	4	GO:0016831
GeneOntologyMolecularFunction	microfilament motor activity	MYH10 MYH11 MYO1B MYH14	4.46e-04	38	189	4	GO:0000146
GeneOntologyMolecularFunction	single-stranded RNA binding	CPEB2 PATL2 PABPN1L PUS1 DDX60L AQR	6.61e-04	111	189	6	GO:0003727
GeneOntologyMolecularFunction	actin binding	GIPC1 MYH10 MYH11 ABL2 SPTB MYO1B PTK2 MYH14 MICAL2 MACF1 MICAL3 TNNI2 MYBPC3	6.67e-04	479	189	13	GO:0003779
GeneOntologyMolecularFunction	cytoskeletal protein binding	GIPC1 CACNA1C MYH10 MYH11 ABL2 MARK1 SPTB APC2 BRSK2 ARFGEF2 MYO1B PTK2 ALMS1 MYH14 MICAL2 MACF1 MICAL3 RP1 BRSK1 TNNI2 HTT MYBPC3	7.41e-04	1099	189	22	GO:0008092
GeneOntologyMolecularFunction	monooxygenase activity	CYP2F1 CYP2J2 COQ6 TH MICAL2 MICAL3	7.96e-04	115	189	6	GO:0004497
GeneOntologyMolecularFunction	phosphatidylinositol-3-phosphate binding	VPS36 PLA2G4E ZFYVE1 SH3PXD2B	1.09e-03	48	189	4	GO:0032266
GeneOntologyMolecularFunction	phosphatidylinositol-3,4,5-trisphosphate binding	MYO1B PLA2G4E ZFYVE1 ARAP1	1.18e-03	49	189	4	GO:0005547
GeneOntologyCellularComponent	glutamatergic synapse	CPEB2 GIPC1 CACNA1C VLDLR MYH10 ABL2 ADAM23 MARK1 SPTB UBE3B ARFGEF2 TAMALIN PTK2 SLITRK2 GRK3 KCNC3 SCN8A PRKAR1A PRKAR1B CTNND1 VCP HTT	5.99e-06	817	191	22	GO:0098978
GeneOntologyCellularComponent	myosin filament	MYH10 MYH11 MYH14 MYBPC3	7.35e-05	25	191	4	GO:0032982
GeneOntologyCellularComponent	myosin II filament	MYH10 MYH14	2.48e-04	3	191	2	GO:0097513
GeneOntologyCellularComponent	dendritic spine	GIPC1 MYH10 ABL2 ARFGEF2 PTK2 GRK3 KCNC3 MTMR2 CTNND1	4.00e-04	242	191	9	GO:0043197
GeneOntologyCellularComponent	postsynapse	GIPC1 CACNA1C MYH10 ABL2 MARK1 SPTB UBE3B APC2 ARFGEF2 TAMALIN PTK2 SLITRK2 GRK3 KCNC2 KCNC3 SCN8A MTMR2 PRKAR1B MACF1 CTNND1 HTT	4.27e-04	1018	191	21	GO:0098794
GeneOntologyCellularComponent	neuron spine	GIPC1 MYH10 ABL2 ARFGEF2 PTK2 GRK3 KCNC3 MTMR2 CTNND1	4.64e-04	247	191	9	GO:0044309
GeneOntologyCellularComponent	brush border	GIPC1 SLC26A3 MYH10 MYH11 MYO1B MYH14 SLC6A20	5.05e-04	152	191	7	GO:0005903
GeneOntologyCellularComponent	lipid droplet	APOB ZFYVE1 ABHD5 VPS13A PISD VCP	6.95e-04	116	191	6	GO:0005811
Domain	Cadherin_tail	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	7.20e-08	37	187	7	PF15974
Domain	Cadherin_CBD	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	7.20e-08	37	187	7	IPR031904
Domain	Malic_OxRdtase	ME1 ME2 ME3	9.88e-07	3	187	3	IPR001891
Domain	Malic_NAD-bd	ME1 ME2 ME3	9.88e-07	3	187	3	IPR012302
Domain	Malic_N_dom	ME1 ME2 ME3	9.88e-07	3	187	3	IPR012301
Domain	MALIC_ENZYMES	ME1 ME2 ME3	9.88e-07	3	187	3	PS00331
Domain	Malic_M	ME1 ME2 ME3	9.88e-07	3	187	3	PF03949
Domain	Malic_M	ME1 ME2 ME3	9.88e-07	3	187	3	SM00919
Domain	malic	ME1 ME2 ME3	9.88e-07	3	187	3	PF00390
Domain	-	ME1 ME2 ME3	9.88e-07	3	187	3	3.40.50.10380
Domain	malic	ME1 ME2 ME3	9.88e-07	3	187	3	SM01274
Domain	Malic_enzyme_CS	ME1 ME2 ME3	9.88e-07	3	187	3	IPR015884
Domain	Cadherin_2	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	3.84e-06	65	187	7	PF08266
Domain	Cadherin_N	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	3.84e-06	65	187	7	IPR013164
Domain	Cadherin_CS	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2 CDH24	1.39e-05	109	187	8	IPR020894
Domain	CADHERIN_1	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2 CDH24	1.82e-05	113	187	8	PS00232
Domain	Cadherin	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2 CDH24	1.82e-05	113	187	8	PF00028
Domain	FAD-bd	COQ6 MICAL2 MICAL3	1.93e-05	6	187	3	IPR002938
Domain	FAD_binding_3	COQ6 MICAL2 MICAL3	1.93e-05	6	187	3	PF01494
Domain	CADHERIN_2	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2 CDH24	1.94e-05	114	187	8	PS50268
Domain	-	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2 CDH24	1.94e-05	114	187	8	2.60.40.60
Domain	CA	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2 CDH24	2.06e-05	115	187	8	SM00112
Domain	Cadherin-like	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2 CDH24	2.20e-05	116	187	8	IPR015919
Domain	Channel_four-helix_dom	CACNA1C CACNA1F NALCN KCNC2 KCNC3 SCN8A	2.21e-05	57	187	6	IPR027359
Domain	-	CACNA1C CACNA1F NALCN KCNC2 KCNC3 SCN8A	2.21e-05	57	187	6	1.20.120.350
Domain	Cadherin	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2 CDH24	2.49e-05	118	187	8	IPR002126
Domain	IQ	MYH10 MYH11 UBE3B MYO1B MYH14 SCN8A	7.76e-05	71	187	6	PF00612
Domain	Kinase-like_dom	EPHB3 ABL2 MARK1 SPEG BRSK2 SIK3 MAPKAPK5 PTK2 GRK3 PI4KB NRK MYLK4 ALPK3 MACF1 PRKCQ BRSK1	1.16e-04	542	187	16	IPR011009
Domain	P-loop_NTPase	DHX16 CPLANE2 MPP1 DNAH3 ABCA1 MYH10 MYH11 DRG2 EP400 PSMC3 MYO1B ZFYVE1 GTPBP2 NOD1 MYH14 ATAD3A TJP2 DDX60L AQR VCP TJP3	1.23e-04	848	187	21	IPR027417
Domain	IQ	MYH10 MYH11 UBE3B MYO1B MYH14 SCN8A	1.62e-04	81	187	6	SM00015
Domain	IQ_motif_EF-hand-BS	MYH10 MYH11 UBE3B MYO1B MYH14 SCN8A	2.88e-04	90	187	6	IPR000048
Domain	CAC1F_C	CACNA1C CACNA1F	2.97e-04	3	187	2	IPR031688
Domain	ZO	TJP2 TJP3	2.97e-04	3	187	2	IPR005417
Domain	CAC1F_C	CACNA1C CACNA1F	2.97e-04	3	187	2	PF16885
Domain	IQ	MYH10 MYH11 UBE3B MYO1B MYH14 SCN8A	3.44e-04	93	187	6	PS50096
Domain	Myosin_N	MYH10 MYH11 MYH14	4.11e-04	15	187	3	PF02736
Domain	Myosin_N	MYH10 MYH11 MYH14	4.11e-04	15	187	3	IPR004009
Domain	Protein_kinase_ATP_BS	EPHB3 ABL2 MARK1 SPEG BRSK2 SIK3 PTK2 GRK3 NRK MYLK4 PRKCQ BRSK1	4.53e-04	379	187	12	IPR017441
Domain	Myosin_head_motor_dom	MYH10 MYH11 MYO1B MYH14	5.50e-04	38	187	4	IPR001609
Domain	MYOSIN_MOTOR	MYH10 MYH11 MYO1B MYH14	5.50e-04	38	187	4	PS51456
Domain	Myosin_head	MYH10 MYH11 MYO1B MYH14	5.50e-04	38	187	4	PF00063
Domain	MYSc	MYH10 MYH11 MYO1B MYH14	5.50e-04	38	187	4	SM00242
Domain	VDCC_L_a1su	CACNA1C CACNA1F	5.90e-04	4	187	2	IPR005446
Domain	cAMP_dep_PK_reg_su	PRKAR1A PRKAR1B	5.90e-04	4	187	2	IPR012198
Domain	K_chnl_volt-dep_Kv3	KCNC2 KCNC3	5.90e-04	4	187	2	IPR003974
Domain	Ca/CaM-dep_Ca-dep_prot_Kinase	MARK1 BRSK2 MAPKAPK5 MYLK4 BRSK1	6.38e-04	69	187	5	IPR020636
Domain	Myosin_tail_1	MYH10 MYH11 MYH14	7.21e-04	18	187	3	PF01576
Domain	Myosin_tail	MYH10 MYH11 MYH14	7.21e-04	18	187	3	IPR002928
Domain	PROTEIN_KINASE_ATP	EPHB3 ABL2 MARK1 SPEG BRSK2 SIK3 MAPKAPK5 PTK2 GRK3 NRK MYLK4 PRKCQ BRSK1	7.51e-04	459	187	13	PS00107
Domain	Myosin-like_IQ_dom	MYH10 MYH11 MYH14	8.50e-04	19	187	3	IPR027401
Domain	-	MYH10 MYH11 MYH14	8.50e-04	19	187	3	4.10.270.10
Domain	Myosin_S1_N	MYH10 MYH11	9.78e-04	5	187	2	IPR008989
Domain	Ion_trans_dom	CACNA1C CACNA1F NALCN KCNC2 KCNC3 SCN8A	1.01e-03	114	187	6	IPR005821
Domain	Ion_trans	CACNA1C CACNA1F NALCN KCNC2 KCNC3 SCN8A	1.01e-03	114	187	6	PF00520
Domain	Prot_kinase_dom	EPHB3 ABL2 MARK1 SPEG BRSK2 SIK3 MAPKAPK5 PTK2 GRK3 NRK MYLK4 PRKCQ BRSK1	1.33e-03	489	187	13	IPR000719
Domain	-	DHX16 CPLANE2 MPP1 DNAH3 ABCA1 DRG2 EP400 PSMC3 ZFYVE1 GTPBP2 NOD1 ATAD3A TJP2 DDX60L AQR VCP TJP3	1.38e-03	746	187	17	3.40.50.300
Domain	PROTEIN_KINASE_DOM	EPHB3 ABL2 MARK1 SPEG BRSK2 SIK3 MAPKAPK5 PTK2 GRK3 NRK MYLK4 PRKCQ BRSK1	1.43e-03	493	187	13	PS50011
Domain	RIIa	PRKAR1A PRKAR1B	1.46e-03	6	187	2	SM00394
Domain	Pentatricopeptide_repeat	POLRMT NCAPG2 HTT	1.51e-03	23	187	3	IPR002885
Domain	GUANYLATE_KINASE_2	MPP1 TJP2 TJP3	1.51e-03	23	187	3	PS50052
Domain	GUANYLATE_KINASE_1	MPP1 TJP2 TJP3	1.51e-03	23	187	3	PS00856
Domain	SH3_2	MPP1 SH3TC2 SH3PXD2B TJP2 TJP3	1.73e-03	86	187	5	PF07653
Domain	SH3_2	MPP1 SH3TC2 SH3PXD2B TJP2 TJP3	1.73e-03	86	187	5	IPR011511
Domain	-	APC2 ARFGEF2 FRYL NCAPG2 VAC14 RRP12 CTNND1 HTT	1.82e-03	222	187	8	1.25.10.10
Domain	Ca_chan_IQ	CACNA1C CACNA1F	2.03e-03	7	187	2	SM01062
Domain	Ca_chan_IQ	CACNA1C CACNA1F	2.03e-03	7	187	2	PF08763
Domain	RIIa	PRKAR1A PRKAR1B	2.03e-03	7	187	2	PF02197
Domain	VDCC_a1su_IQ	CACNA1C CACNA1F	2.03e-03	7	187	2	IPR014873
Domain	GPHH	CACNA1C CACNA1F	2.03e-03	7	187	2	PF16905
Domain	GPHH_dom	CACNA1C CACNA1F	2.03e-03	7	187	2	IPR031649
Domain	Guanylate_kin	MPP1 TJP2 TJP3	2.17e-03	26	187	3	PF00625
Domain	GK/Ca_channel_bsu	MPP1 TJP2 TJP3	2.17e-03	26	187	3	IPR008145
Domain	Guanylate_kin-like_dom	MPP1 TJP2 TJP3	2.17e-03	26	187	3	IPR008144
Domain	GuKc	MPP1 TJP2 TJP3	2.17e-03	26	187	3	SM00072
Domain	ARM-type_fold	APC2 ARFGEF2 APOB FRYL NCAPG2 VAC14 RRP12 CTNND1 EIF3M HTT	2.26e-03	339	187	10	IPR016024
Domain	-	COQ6 MICAL2 MICAL3 OSGIN2	2.38e-03	56	187	4	3.50.50.60
Domain	FAD/NAD-binding_dom	COQ6 MICAL2 MICAL3 OSGIN2	2.54e-03	57	187	4	IPR023753
Domain	PDZ	MPP1 GIPC1 TAMALIN PRX TJP2 TJP3	2.99e-03	141	187	6	PF00595
Pubmed	Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons.	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	8.68e-13	15	192	7	15640798
Pubmed	Alpha protocadherins and Pyk2 kinase regulate cortical neuron migration and cytoskeletal dynamics via Rac1 GTPase and WAVE complex in mice.	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	2.60e-12	17	192	7	29911975
Pubmed	CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity.	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	4.23e-12	18	192	7	15570159
Pubmed	Genomic organization of the family of CNR cadherin genes in mice and humans.	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	4.23e-12	18	192	7	10662547
Pubmed	Developmental epigenetic modification regulates stochastic expression of clustered protocadherin genes, generating single neuron diversity.	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	4.48e-11	24	192	7	24698270
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	1.50e-10	28	192	7	15347688
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	BDP1 CACNA1C MYH10 TBKBP1 SPTB AFF3 GAS6 HECTD4 FRYL ME2 BDH1 PTK2 GRK3 TULP4 TECPR2 MYH14 ATAD3A MICAL2 SEL1L3 ANKRD11 PRKAR1B MACF1 PISD MICAL3 CTNND1 TMEM143 DOCK6 CLEC16A EIF3M ARAP1 HTT	2.02e-10	1489	192	31	28611215
Pubmed	Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex.	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4	2.19e-09	11	192	5	9655502
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	TBKBP1 ABL2 GATAD2A MARK1 AFF3 GAS6 BRSK2 MYO1B SIK3 MAPKAPK5 NFU1 PTK2 PRX SLC30A6 NRK PRKAR1A PRKAR1B DDX60L CTNND1 BRSK1 EIF3M DCAF7	7.90e-09	910	192	22	36736316
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TBKBP1 RHBDF1 EP400 SPEG UBE3B HECTD4 POLRMT ARFGEF2 FRYL MAPKAPK5 FBXO46 LPIN3 VAC14 SH3PXD2B TULP4 RRP12 SCN8A ANKRD11 MICAL3 DOCK6 RGL2 ARAP1 HTT TJP3	1.24e-08	1105	192	24	35748872
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	MPP1 BDP1 CACNA1C RBM15 SPEG POLR2B POLRMT VPS36 ME1 RRP12 ANKRD11 TJP2 MICAL3 RP1 CTNND1 DCAF7	2.04e-08	497	192	16	36774506
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	2.93e-08	57	192	7	32633719
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	3.32e-08	58	192	7	30377227
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DHX16 DNAJB11 RBM15 MYH10 GATAD2A EP400 POLR2B POLRMT PSMC3 OAS3 MYO1B NCAPG2 PTK2 GSTP1 WASHC5 MYH14 BAZ1A ATAD3A MICAL2 RRP12 MACF1 DDX60L CTNND1 EIF3M AQR VCP	3.43e-08	1353	192	26	29467282
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	CACNA1F ABL2 CENPA PCDHA12 PCDHA8 PCDHA5 PCDHA3 PCDHA2 PRX TGOLN2 TULP4 VPS13A RGL2	4.30e-08	329	192	13	17474147
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RBM15 ABL2 DRG2 CARMIL2 BRSK2 FRYL SIK3 SPICE1 LPIN3 SH3PXD2B ALMS1 PI4KB ANKRD11 TJP2 MACF1 CTNND1 DOCK6 RGL2 AQR DCAF7	7.55e-08	861	192	20	36931259
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	1.02e-07	68	192	7	11230163
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	1.52e-07	72	192	7	10380929
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	1.84e-07	74	192	7	10817752
Pubmed	The DNA sequence and comparative analysis of human chromosome 5.	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	2.02e-07	75	192	7	15372022
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	2.43e-07	77	192	7	10835267
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	3.17e-07	80	192	7	10716726
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CPEB2 MYH10 MYH11 CARMIL2 MARK1 SPTB BRSK2 ARFGEF2 PSMC3 MTMR1 GSTP1 WASHC5 MYH14 ATAD3A MICAL2 MTMR2 FBXO41 PRKAR1A TJP2 MACF1 UQCRQ MICAL3 CTNND1 BRSK1 VCP	3.85e-07	1431	192	25	37142655
Pubmed	Proteins of the CNR family are multiple receptors for Reelin.	PCDHA13 PCDHA8 PCDHA5 PCDHA4	4.30e-07	12	192	4	10612399
Pubmed	14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK.	MARK1 BRSK2 SIK3 BRSK1 VCP	6.20e-07	30	192	5	16306228
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	DHX16 RBM15 MYH10 POLRMT PSMC3 MYO1B FRYL ME2 GSTP1 MYH14 ATAD3A RRP12 TJP2 MACF1 AQR VCP	8.07e-07	653	192	16	22586326
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	DHX16 GIPC1 DNAJB11 PDE3A MYH10 DRG2 POLR2B COQ6 POLRMT PSMC3 MYO1B APOB SHOC2 GSTP1 BAZ1A PRKAR1A MACF1 PISD EIF3M GAA AQR VCP DCAF7	9.09e-07	1297	192	23	33545068
Pubmed	LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.	MARK1 BRSK2 SIK3 BRSK1	1.17e-06	15	192	4	14976552
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	DHX16 MPP1 RBM15 MYH10 DRG2 GATAD2A EP400 POLR2B PSMC3 DBT YTHDC1 BDH1 LIG1 WASHC5 ATAD3A RRP12 PUS1 TJP2 UQCRQ PRKCQ EIF3M AQR DCAF7	1.19e-06	1318	192	23	30463901
Pubmed	Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women.	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2 SIK3 FBXO46	1.40e-06	193	192	9	22589738
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	THOC1 RBM15 MYH10 POLR2B PSMC3 MYO1B DBT YTHDC1 ME1 BDH1 NFU1 SPICE1 GSTP1 ARNT TULP4 MYH14 ATAD3A MICAL2 CTNND1 AQR VCP TJP3	1.74e-06	1247	192	22	27684187
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	THOC1 DHX16 DNAJB11 RBM15 MYH10 EP400 MARK1 POLR2B HECTD4 MTMR1 MYO1B SIK3 DBT YTHDC1 ATAD3A RRP12 MACF1 DOCK6 AQR VCP	2.65e-06	1082	192	20	38697112
Pubmed	Phosphorylation of microtubule-associated protein tau by AMPK-related kinases.	MARK1 BRSK2 BRSK1	3.27e-06	6	192	3	21985311
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	VLDLR DNAJB11 GATAD2A EP400 POLR2B GAS6 POLRMT OAS3 C16orf96 SIK3 DBT PLEKHN1 SLC5A11 GTPBP2 ALMS1 MACF1 TAF13 KAT14 VCP DCAF7	4.20e-06	1116	192	20	31753913
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	THOC1 DHX16 DNAJB11 RBM15 GATAD2A EP400 POLR2B MYO1B GSTP1 MYH14 BAZ1A ATAD3A RRP12 PRKAR1A TJP2 MACF1 CTNND1 AQR VCP	4.52e-06	1024	192	19	24711643
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	4.66e-06	119	192	7	28625976
Pubmed	The TIP60 Complex Is a Conserved Coactivator of HIF1A.	EP400 POLR2B POLRMT MYO1B BDH1 ARNT ATAD3A	4.92e-06	120	192	7	27320910
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	DHX16 ZC3H12A DRG2 POLR2B ZFYVE1 SPICE1 LPIN3 VAC14 WASHC5 PI4KB PRKAR1A TJP2 PRKAR1B PPP1R35 CTNND1 TAF13 DOCK6 TJP3 DCAF7	5.48e-06	1038	192	19	26673895
Pubmed	Intracellular lipidation of newly synthesized apolipoprotein A-I in primary murine hepatocytes.	ABCA1 APOB TGOLN2	5.70e-06	7	192	3	16204232
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	DNAJB11 PDE3A DRG2 DCPS POLR2B ARFGEF2 PSMC3 FRYL VPS36 DPP3 ME1 LIG1 WASHC5 MYH14 MTMR2 PRKAR1A PUS1 TJP2 PRKAR1B MACF1 EIF3M VCP HTT	6.14e-06	1455	192	23	22863883
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	THOC1 DHX16 RBM15 MYH10 POLR2B POLRMT PSMC3 MYO1B APOB DBT ME2 GSTP1 MYH14 BAZ1A ATAD3A RRP12 PRKAR1A PUS1 CTNND1 EIF3M AQR DCAF7	1.43e-05	1425	192	22	30948266
Pubmed	SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243.	MYH10 MYH11 DBT MYH14 EIF3M VCP	1.51e-05	95	192	6	33863777
Pubmed	LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.	DNAJB11 MYH10 MYH11 MYO1B ME1 GSTP1 MYH14 ATAD3A MACF1 VCP	1.54e-05	327	192	10	31409639
Pubmed	USP7 controls NGN3 stability and pancreatic endocrine lineage development.	MYH10 SPEG MYO1B ATAD3A MACF1	1.76e-05	58	192	5	37117185
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	MYH10 MYH11 ARFGEF2 MYO1B FRYL MYH14 RRP12 DOCK6	1.79e-05	202	192	8	33005030
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DHX16 MYH10 EP400 SPEG VPS8 RRP12 SEL1L3 MACF1 MICAL3 CLEC16A AQR	1.82e-05	407	192	11	12693553
Pubmed	Large-scale concatenation cDNA sequencing.	CACNA1C ADAM23 POLR2B MFSD9 BTBD2 SPICE1 SLITRK2 ABHD5 MICAL2 VPS13A PRKAR1A PISD MIR22HG	1.84e-05	568	192	13	9110174
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	MPP1 CARMIL2 RHBDF1 ARFGEF2 MTMR1 APOB PLEKHN1 FRMD4A SLITRK2 MICAL2 NRK MICAL3 CTNND1	1.87e-05	569	192	13	30639242
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	DNAJB11 MYH10 MARK1 BRSK2 DBT SHOC2 BDH1 FRMD4A WASHC5 ATAD3A FBXO41 PRKAR1A TJP2 PRKAR1B MACF1 UQCRQ CTNND1 CLEC16A VCP	2.00e-05	1139	192	19	36417873
Pubmed	A "double adaptor" method for improved shotgun library construction.	CACNA1C ADAM23 POLR2B MFSD9 BTBD2 SPICE1 SLITRK2 ABHD5 MICAL2 VPS13A PRKAR1A PISD MIR22HG	2.05e-05	574	192	13	8619474
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SH3TC2 MYH11 MARK1 BRSK2 YTHDC1 FCHO1 PRX ALMS1 TULP4 ATAD3A MACF1 MICAL3	2.13e-05	493	192	12	15368895
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	TBKBP1 VPS8 MICAL2 SEL1L3 MACF1 ARAP1	2.15e-05	101	192	6	9872452
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	RBM15 AFF3 APOB YTHDC1 GTPBP2 ATAD3A RRP12 MTMR2 PRKAR1A MACF1 DOCK6 EIF3M	2.26e-05	496	192	12	31343991
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	DNAJB11 RBM15 MYH10 POLR2B PSMC3 MTMR1 MYO1B DBT SHOC2 ME1 SPICE1 WASHC5 RRP12 VPS13A MTMR2 PUS1 MICAL3 CTNND1	2.31e-05	1049	192	18	27880917
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	THOC1 DHX16 RBM15 MYH10 GATAD2A POLR2B POLRMT OAS3 MYO1B DBT YTHDC1 GSTP1 ATAD3A RRP12 TJP2 PISD CTNND1 EIF3M AQR DCAF7	2.35e-05	1257	192	20	36526897
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	SPEG FRMD4A SH3PXD2B TULP4 ALPK3 MICAL3 DOCK6	2.41e-05	153	192	7	10718198
Pubmed	STK11 is required for the normal program of ciliated cell differentiation in airways.	MARK1 BRSK2 SIK3 BRSK1	2.52e-05	31	192	4	31636950
Pubmed	Charcot-Marie-Tooth Neuropathy Type 4 – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY	SH3TC2 PRX MTMR2	2.65e-05	11	192	3	20301641
Pubmed	Promoter for the regulatory type I beta subunit of the 3',5'-cyclic adenosine monophosphate-dependent protein kinase directs transgene expression in the central nervous system.	PRKAR1A PRKAR1B	3.03e-05	2	192	2	1448119
Pubmed	The AAA-ATPase p97 facilitates degradation of apolipoprotein B by the ubiquitin-proteasome pathway.	APOB VCP	3.03e-05	2	192	2	18550891
Pubmed	Characterization of Ca2+-binding protein 5 knockout mouse retina.	CACNA1C CABP5	3.03e-05	2	192	2	18586882
Pubmed	Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner.	MYH14 MYBPC3	3.03e-05	2	192	2	34051236
Pubmed	Novel mutations in the PRX and the MTMR2 genes are responsible for unusual Charcot-Marie-Tooth disease phenotypes.	PRX MTMR2	3.03e-05	2	192	2	21741241
Pubmed	Hepatic ABCA1 deficiency is associated with delayed apolipoprotein B secretory trafficking and augmented VLDL triglyceride secretion.	ABCA1 APOB	3.03e-05	2	192	2	28694219
Pubmed	Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species.	ME1 ME3	3.03e-05	2	192	2	33619771
Pubmed	Functional roles of the tetramer organization of malic enzyme.	ME1 ME3	3.03e-05	2	192	2	19416979
Pubmed	BRSK2 is a valosin-containing protein (VCP)-interacting protein that affects VCP functioning in endoplasmic reticulum-associated degradation.	BRSK2 VCP	3.03e-05	2	192	2	23907667
Pubmed	Diacylglycerol promotes centrosome polarization in T cells via reciprocal localization of dynein and myosin II.	MYH10 PRKCQ	3.03e-05	2	192	2	23818610
Pubmed	Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue.	MYH10 MYH11	3.03e-05	2	192	2	10906735
Pubmed	Myosin II isoform switching mediates invasiveness after TGF-β-induced epithelial-mesenchymal transition.	MYH10 MYH14	3.03e-05	2	192	2	22025714
Pubmed	Mitochondrial malic enzyme (E.C.1.1.1.40) in human leukocytes: formal genetics and population genetics.	ME2 ME3	3.03e-05	2	192	2	511162
Pubmed	VCP/p97 controls signals of the ERK1/2 pathway transmitted via the Shoc2 scaffolding complex: novel insights into IBMPFD pathology.	SHOC2 VCP	3.03e-05	2	192	2	31091164
Pubmed	Cardiac myosin binding protein-C phosphorylation in a {beta}-myosin heavy chain background.	MYH10 MYBPC3	3.03e-05	2	192	2	19237661
Pubmed	Forward-genetics analysis of sleep in randomly mutagenized mice.	SIK3 NALCN	3.03e-05	2	192	2	27806374
Pubmed	Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis.	MYH10 MYH11	3.03e-05	2	192	2	7916668
Pubmed	The ATPase VCP/p97 functions as a disaggregase against toxic Huntingtin-exon1 aggregates.	VCP HTT	3.03e-05	2	192	2	30069866
Pubmed	Isozyme-Specific Role of SAD-A in Neuronal Migration During Development of Cerebral Cortex.	BRSK2 BRSK1	3.03e-05	2	192	2	30307479
Pubmed	Constriction velocities of renal afferent and efferent arterioles of mice are not related to SMB expression.	MYH10 MYH11	3.03e-05	2	192	2	16316347
Pubmed	Cloning and functional characterization of the 5' flanking region of the human mitochondrial malic enzyme gene. Regulatory role of Sp1 and AP-2.	ME1 ME2	3.03e-05	2	192	2	11358520
Pubmed	HIF-1beta determines ABCA1 expression under hypoxia in human macrophages.	ABCA1 ARNT	3.03e-05	2	192	2	19828131
Pubmed	Directional ABCA1-mediated cholesterol efflux and apoB-lipoprotein secretion in the retinal pigment epithelium.	ABCA1 APOB	3.03e-05	2	192	2	30076206
Pubmed	State-of-the-art computational methods to predict protein-protein interactions with high accuracy and coverage.	ME2 ME3	3.03e-05	2	192	2	37401192
Pubmed	SAD: a presynaptic kinase associated with synaptic vesicles and the active zone cytomatrix that regulates neurotransmitter release.	BRSK2 BRSK1	3.03e-05	2	192	2	16630837
Pubmed	Laminin stimulates and guides axonal outgrowth via growth cone myosin II activity.	MYH10 MYH14	3.03e-05	2	192	2	15880105
Pubmed	Purification and properties of cytosolic and mitochondrial malic enzyme isolated from human brain.	ME1 ME2	3.03e-05	2	192	2	7757881
Pubmed	Molecular mechanism for the regulation of human mitochondrial NAD(P)+-dependent malic enzyme by ATP and fumarate.	ME1 ME2	3.03e-05	2	192	2	12121650
Pubmed	Palmitoylation of δ-catenin promotes kinesin-mediated membrane trafficking of Nav1.6 in sensory neurons to promote neuropathic pain.	SCN8A CTNND1	3.03e-05	2	192	2	29588412
Pubmed	Expression of Malic Enzymes in Sebaceous Lesions.	ME1 ME2	3.03e-05	2	192	2	26381116
Pubmed	Different regulatory properties of the cytosolic and mitochondrial forms of malic enzyme isolated from human brain.	ME1 ME2	3.03e-05	2	192	2	7496989
Pubmed	Novel isozymes of cAMP-dependent protein kinase exist in human cells due to formation of RI alpha-RI beta heterodimeric complexes.	PRKAR1A PRKAR1B	3.03e-05	2	192	2	8407966
Pubmed	Ablation of nonmuscle myosin II-B and II-C reveals a role for nonmuscle myosin II in cardiac myocyte karyokinesis.	MYH10 MYH14	3.03e-05	2	192	2	20861308
Pubmed	Investigating the regulation of brain-specific kinases 1 and 2 by phosphorylation.	BRSK2 BRSK1	3.03e-05	2	192	2	18339622
Pubmed	Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin.	MYH10 MYH11 MYH14	3.51e-05	12	192	3	8424456
Pubmed	Identification of novel Ack1-interacting proteins and Ack1 phosphorylated sites in mouse brain by mass spectrometry.	MYH10 FRMD4A FBXO41 TJP2 MICAL3	3.56e-05	67	192	5	29254152
Pubmed	Identification of FBXO25-interacting proteins using an integrated proteomics approach.	MYH10 MYH11 PSMC3 MYO1B MYH14 ATAD3A	3.85e-05	112	192	6	20473970
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	RBM15 TBKBP1 MARK1 PSMC3 FRYL SPICE1 ALMS1 PI4KB TJP2 DOCK6 DCAF7	4.19e-05	446	192	11	24255178
Pubmed	DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC.	DHX16 POLRMT GRK3 CTNND1 TAF13 VCP	5.17e-05	118	192	6	37105989
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	DHX16 UBE3B POLRMT SIK3 NCAPG2 PTK2 LPIN3 GTPBP2 ARNT WASHC5 MICAL3 CLEC16A AQR	7.29e-05	650	192	13	38777146
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	THOC1 DHX16 RBM15 MYH10 MYH11 DRG2 GATAD2A EP400 OAS3 MYO1B APOB FBXO46 BDH1 C3P1 MYH14 BAZ1A TJP2 CTNND1 VCP DCAF7	7.82e-05	1371	192	20	36244648
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	RBM15 MYH10 GATAD2A POLRMT MYO1B YTHDC1 WASHC5 MYH14 BAZ1A ATAD3A RRP12 TJP2 CTNND1 AQR VCP	7.99e-05	847	192	15	35850772
Interaction	PCDHA10 interactions	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	8.33e-10	22	188	7	int:PCDHA10
Interaction	YWHAH interactions	RBM15 MYH11 ABL2 DRG2 CARMIL2 MARK1 SPEG HECTD4 PSMC3 FRYL SIK3 LPIN3 FRMD4A SH3PXD2B ALMS1 PI4KB ANKRD11 TJP2 MACF1 CTNND1 DOCK6 RGL2 CLEC16A AQR VCP HTT DCAF7	4.14e-06	1102	188	27	int:YWHAH
Interaction	TOP3B interactions	THOC1 RBM15 MYH10 TBKBP1 RHBDF1 EP400 SPEG RRM2B SPTB UBE3B HECTD4 POLRMT ARFGEF2 MYO1B APOB FRYL MAPKAPK5 FBXO46 LPIN3 VAC14 SH3PXD2B TULP4 ATAD3A RRP12 SCN8A ANKRD11 MICAL3 DOCK6 RGL2 ARAP1 HTT TJP3	5.83e-06	1470	188	32	int:TOP3B
Interaction	PCDHA7 interactions	PCDHA12 PCDHA8 PCDHA4 PCDHA2	6.82e-06	14	188	4	int:PCDHA7
Interaction	PCDHA8 interactions	PCDHA13 PCDHA12 PCDHA8 PCDHA4 PCDHA3 PCDHA2	1.21e-05	55	188	6	int:PCDHA8
Interaction	FBXO22 interactions	MPP1 BDP1 CACNA1C RBM15 SPEG POLR2B POLRMT VPS36 ME1 TGOLN2 RRP12 ANKRD11 TJP2 MICAL3 RP1 CTNND1 DCAF7	1.31e-05	540	188	17	int:FBXO22
Interaction	YWHAG interactions	RBM15 MYH10 ABL2 CARMIL2 MARK1 SPEG HECTD4 FRYL SIK3 MAPKAPK5 PTK2 TGOLN2 SPICE1 LPIN3 FRMD4A ALMS1 BAZ1A PI4KB ANKRD11 TJP2 MACF1 PRKCQ CTNND1 RGL2 AQR VCP HTT DCAF7	1.40e-05	1248	188	28	int:YWHAG
Interaction	MEN1 interactions	THOC1 RBM15 MYH10 DRG2 GATAD2A EP400 POLR2B POLRMT MYO1B YTHDC1 BDH1 WASHC5 MYH14 BAZ1A ATAD3A RRP12 PRKAR1A PUS1 TJP2 PISD CTNND1 AQR VCP DCAF7	3.32e-05	1029	188	24	int:MEN1
Cytoband	5q31	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	6.00e-07	115	192	7	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2 UQCRQ	4.04e-05	298	192	8	chr5q31
Cytoband	19q13.33	CABP5 GARIN5A KCNC3 MYH14 TMEM143	8.74e-05	106	192	5	19q13.33
Cytoband	1q21	ITGA10 RFX5 ARNT PI4KB	5.97e-04	91	192	4	1q21
GeneFamily	Clustered protocadherins	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	2.86e-07	64	125	7	20
GeneFamily	Myosin heavy chains	MYH10 MYH11 MYH14	1.38e-04	15	125	3	1098
GeneFamily	PDZ domain containing	MPP1 GIPC1 TAMALIN PRX TJP2 TJP3	6.60e-04	152	125	6	1220
GeneFamily	Calcium voltage-gated channel subunits\|Membrane associated guanylate kinases	MPP1 TJP2 TJP3	7.47e-04	26	125	3	904
GeneFamily	Regulatory factor X family	RFX8 RFX5	1.29e-03	8	125	2	1153
ToppCell	LPS_only-Hematopoietic_Myeloid-Dendritic_cells-pDC\|LPS_only / Treatment groups by lineage, cell group, cell type	VLDLR CARMIL2 FGD2 GAS6 MTMR1 SHOC2 TAMALIN FCHO1 SEL1L3 TNNI2	1.60e-08	198	192	10	d205dfcfe1f20e1e21bf84759e723d9e6e610a5c
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	CACNA1C PDE3A MYH10 MYH11 SPEG SPTB ITGA10 TBX18 BRSK1	4.87e-08	167	192	9	c4e321bb87512ea839f324c92c0f1afea891483f
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	CACNA1C PDE3A MYH10 MYH11 MARK1 SPEG SPTB TBX18 MICAL3	6.27e-08	172	192	9	c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf
ToppCell	distal-mesenchymal-Airway_Smooth_Muscle-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CACNA1C PDE3A MYH10 MYH11 SPEG SPTB MYO1B F10 MOCS1	2.27e-07	200	192	9	f09eaa52e11262ec47f3dcb4d890e240eaaa2b3d
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	CACNA1C PDE3A MYH10 MYH11 MARK1 SPEG ALPK3 BRSK1	5.11e-07	161	192	8	64891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABL2 FGD2 TAMALIN TBX18 FRMD4A ABHD5 ALPK3 GAA	5.61e-07	163	192	8	a6e272e043859858084b8d4d96fa4ff9e6eca454
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C PDE3A MYH10 MYH11 SPEG SPTB KCNC2 MOCS1	6.15e-07	165	192	8	8a82e20c9b1156bb4bbc16f7785abb04458d671b
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-pDC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A1BG PATL2 FGD2 TAMALIN FCHO1 SEL1L3 FBXO41 TNNI2	8.43e-07	172	192	8	d40a8bd61114b49a5837c836136a13c37c8f7de0
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C PDE3A MYH11 MARK1 SPTB MYO1B DOCK6 MOCS1	1.09e-06	178	192	8	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	COVID-19-Heart-CM_4\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C PDE3A ADAM23 SPTB TECPR2 ALPK3 MIR22HG MYBPC3	1.34e-06	183	192	8	2902b6e8aa9a6f62bc1a792c971ab7f651a8e676
ToppCell	Adult-Mesenchymal-pericyte_cell-D122\|Adult / Lineage, Cell type, age group and donor	CACNA1C PDE3A MYH11 MARK1 SPTB RFX8 DOCK6 MOCS1	1.34e-06	183	192	8	fc31a43a637423cb3bb9aa184a3a889a0b9aaea6
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C PDE3A CYP2J2 ADAM23 SPTB NALCN ALPK3 MYBPC3	1.40e-06	184	192	8	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDE3A MYH11 MARK1 MYO1B PCDHA5 PCDHA3 DOCK6 MOCS1	1.52e-06	186	192	8	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C SPEG SPTB ME3 MYH14 MYLK4 ALPK3 MYBPC3	1.92e-06	192	192	8	f6a4e348406a852ace9fb21db8fbdff539217645
ToppCell	droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C SPEG SPTB ME3 MYH14 MYLK4 ALPK3 MYBPC3	1.92e-06	192	192	8	1a0c25106ae08eac912a4edd5fc1a3ee776f69c2
ToppCell	LPS_only-Myeloid-Dendritic_cells-pDC\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FGD2 AFF3 GAS6 TAMALIN FCHO1 SEL1L3 TNNI2	2.02e-06	135	192	7	0afe232aa1a1e6c37a5b3183b67d7fa07e0ea791
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 AFF3 SIK3 SHOC2 TAMALIN SEL1L3 PRKAR1A MICAL3	2.16e-06	195	192	8	481989d2e5bd2582da3d86b0155c4d6615317067
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 AFF3 SIK3 SHOC2 TAMALIN SEL1L3 PRKAR1A MICAL3	2.16e-06	195	192	8	6108a27523d1b93a7fbe35cb95704a5ad9071e3c
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)\|Adult / Lineage, Cell type, age group and donor	MPP1 ABCA1 FGD2 FRMD4A SH3PXD2B ABHD5 GRK3 DDX60L	2.16e-06	195	192	8	55e25f702af19146a161861cfd15f40bbda1dc35
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1C MYH10 ADAM23 AFF3 FRMD4A KCNC2 MICAL2 SCN8A	2.24e-06	196	192	8	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C PDE3A MYH10 MYH11 MARK1 SPEG TBX18 MICAL3	2.42e-06	198	192	8	bd42c03e384e64f61b02618cf1a5440033bb04b2
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1C MYH10 ADAM23 AFF3 FRMD4A KCNC2 MICAL2 SCN8A	2.42e-06	198	192	8	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CACNA1C PDE3A MYH10 MYH11 MARK1 SPEG SPTB BRSK2	2.51e-06	199	192	8	706b7de777ff86eb22e538ccd5c2987ceb6be308
ToppCell	distal-2-mesenchymal-Airway_Smooth_Muscle\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CACNA1C PDE3A MYH10 MYH11 SPEG SPTB F10 MOCS1	2.51e-06	199	192	8	af226a6c50747dad9ca696463e715913b3ac17c0
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CACNA1C PDE3A MYH10 MYH11 MARK1 SPEG SPTB BRSK2	2.51e-06	199	192	8	471738f2059e20407572d9c4cbd11812068333ea
ToppCell	Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C PDE3A MYH10 MYH11 SPEG SPTB F10 MOCS1	2.51e-06	199	192	8	7c272a1aa7f3e931ad5d20809719d85b3bce4cb0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CACNA1C PDE3A MYH10 MYH11 MARK1 SPEG SPTB BRSK2	2.51e-06	199	192	8	690a4f84b205532c4c9e5c19d5ae430d0655f421
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	BDP1 CACNA1C ADAM23 AFF3 FRMD4A KCNC2 MICAL2 SCN8A	2.60e-06	200	192	8	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	distal-1-mesenchymal-Airway_Smooth_Muscle\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PDE3A MYH10 MYH11 SPEG SPTB BRSK2 F10 MOCS1	2.60e-06	200	192	8	4d4d227d4df7cab7293bc8005ca1b0441983f39a
ToppCell	distal-mesenchymal-Airway_Smooth_Muscle\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CACNA1C PDE3A MYH10 MYH11 SPEG BRSK2 F10 MOCS1	2.60e-06	200	192	8	1b5ac5b3ddd4df32e940531cc020998f8cd95c2c
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	LARGE2 ABL2 SLC5A11 LPIN3 NRK SLC6A20	5.66e-06	103	192	6	39d8cfb899ca88c72ebe021d66cc21ae2eb6a1cc
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	LARGE2 ABL2 SLC5A11 LPIN3 NRK SLC6A20	5.66e-06	103	192	6	01a7baaa0c3903bd00e37717856d2c1ac21bf2c8
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C PDE3A MYH11 SPEG BRSK2 ITGA10 BRSK1	7.02e-06	163	192	7	8f24cef152f5965727bbeee116bd26c75cbba82a
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C PDE3A MYH11 MARK1 SPEG SPTB MOCS1	7.02e-06	163	192	7	51dee6c21cbeca4e17d1cc386e203f0c403089e8
ToppCell	facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C PDE3A MYH11 MARK1 POLRMT PABPN1L TG	9.59e-06	171	192	7	b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949
ToppCell	facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C PDE3A MYH11 MARK1 POLRMT PABPN1L TG	9.59e-06	171	192	7	9d825a2e799421af4f2cf4f4dc8e239b5d00476d
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	CACNA1C PDE3A MYH11 MARK1 MYO1B FRMD4A MOCS1	9.59e-06	171	192	7	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	Adult-Mesenchymal-pericyte_cell-D231\|Adult / Lineage, Cell type, age group and donor	CACNA1C PDE3A MYH11 MARK1 SPEG MYO1B MOCS1	9.96e-06	172	192	7	858cee96c1c06160863b4adcd7023c0d678bd50f
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	CACNA1C PDE3A MYH10 MYH11 MARK1 SPEG MICAL3	1.03e-05	173	192	7	a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C PDE3A MYH10 MYH11 MARK1 SPEG MICAL3	1.03e-05	173	192	7	5416b092321c7d9b63f0418c60f2402a138355bf
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C PDE3A CYP2J2 SPTB ALPK3 DDX60L MYBPC3	1.16e-05	176	192	7	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	droplet-Thymus-nan-18m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VLDLR EFCAB10 ADAM23 GAS6 GRK3 MYH14 TNNI2	1.44e-05	182	192	7	f6717e97e87513384149800c9fd8dea821ab9393
ToppCell	droplet-Thymus-nan-18m-Myeloid-professional_antigen_presenting_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VLDLR EFCAB10 ADAM23 GAS6 GRK3 MYH14 TNNI2	1.44e-05	182	192	7	c33b0d532822186a1e8e645500347972468718c0
ToppCell	Adult-Mesenchymal-pericyte_cell\|Adult / Lineage, Cell type, age group and donor	CACNA1C PDE3A MYH11 MARK1 SPTB DOCK6 MOCS1	1.71e-05	187	192	7	62759efb660179402fb574ce5701c89a2e17bcfe
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C PDE3A MYH11 MARK1 MYO1B DOCK6 MOCS1	1.71e-05	187	192	7	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A MYH11 SPEG AFF3 TBX18 NALCN MICAL2	1.77e-05	188	192	7	b2d68a32314e9b099ed74d974079ad96359d1ae3
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C PDE3A MYH11 MARK1 MYO1B DOCK6 MOCS1	1.77e-05	188	192	7	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	CACNA1C PDE3A MYH11 MARK1 MYO1B DOCK6 MOCS1	1.83e-05	189	192	7	d7ed96add29f219183c802895fbff519b627f635
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A MYH10 MYH11 AFF3 TBX18 NALCN MICAL2	1.90e-05	190	192	7	2e88e366d377d74deb53a4ea870973ce5c6532e8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A MYH10 MYH11 AFF3 TBX18 NALCN MICAL2	1.90e-05	190	192	7	0028f886c789ba238c031eae5d96acaed4af8c25
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	CACNA1C PDE3A SIK3 ALPK3 MICAL3 DDX60L MYBPC3	1.90e-05	190	192	7	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C PDE3A MYH11 MARK1 MYO1B DOCK6 MOCS1	1.90e-05	190	192	7	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C PDE3A MYH11 MARK1 MYO1B DOCK6 MOCS1	1.90e-05	190	192	7	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	Control-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	CACNA1C PDE3A MYH11 SPEG SPTB BRSK2 MICAL2	1.96e-05	191	192	7	2da83c493e60ad0278848957645277d76737a188
ToppCell	Mesenchymal-vascular_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	CACNA1C PDE3A MYH10 MYH11 MARK1 SPEG SPTB	1.96e-05	191	192	7	fd89fbc62aa1c73e0f659991e3bd726a0c97bd68
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A MYH11 AFF3 MYO1B TBX18 NALCN MICAL2	2.03e-05	192	192	7	24e2f15f5767a97eb3b389922bcfd7b13805e1ce
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	A1BG PDE3A MYH11 MARK1 SPTB GAS6 MOCS1	2.03e-05	192	192	7	55f95454399fd533df75db06584eaa48d6ee3830
ToppCell	CTRL-Myeloid-Alveolar_Macrophage\|Myeloid / Disease state, Lineage and Cell class	ME1 TGOLN2 GSTP1 FRMD4A ABHD5 TNNI2 GAA	2.10e-05	193	192	7	80871d963c23a6befe58e5e60b7f7d1a1b227ce2
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 VLDLR AFF3 SHOC2 TAMALIN SEL1L3 VCP	2.10e-05	193	192	7	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	PDE3A MYH11 MARK1 SPTB MYO1B PTK2 MOCS1	2.10e-05	193	192	7	ba6eb29478d16589172f48f9992e5116328c81d6
ToppCell	18-Airway-Mesenchymal-Pericyte\|Airway / Age, Tissue, Lineage and Cell class	PDE3A MYH11 SPTB GAS6 MYO1B PTK2 MOCS1	2.10e-05	193	192	7	9f4ba9c29ab8071d57e4187085ec3a47ab61e968
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A MYH10 MYH11 SPEG AFF3 TBX18 MICAL2	2.17e-05	194	192	7	5c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A MYH10 MYH11 SPEG AFF3 TBX18 MICAL2	2.17e-05	194	192	7	ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|lung / Disease (COVID-19 only), tissue and cell type	CACNA1C PDE3A MYH11 MARK1 SPEG MYO1B MOCS1	2.17e-05	194	192	7	5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A MYH11 SPEG AFF3 TBX18 NALCN MICAL2	2.17e-05	194	192	7	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical\|TCGA-Thryoid / Sample_Type by Project: Shred V9	EPHB3 MYH10 FOXQ1 PLEKHN1 NOD1 SEL1L3 CLEC16A	2.17e-05	194	192	7	b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MPP1 ABCA1 FGD2 ME1 FRMD4A SH3PXD2B GRK3	2.24e-05	195	192	7	247803cf58c6d9c561a52aa34e581188ddad197e
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 FRYL GRK3 TULP4 VPS13A ANKRD11 MACF1	2.24e-05	195	192	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A MYH11 SPEG AFF3 TBX18 NALCN MICAL2	2.32e-05	196	192	7	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	367C-Fibroblasts-Fibroblast-K_(Pericytes)\|367C / Donor, Lineage, Cell class and subclass (all cells)	PDE3A MYH11 SPEG BRSK2 F10 PTK2 MOCS1	2.32e-05	196	192	7	c390ef0adff35111989a30dff86b7c5db1a89873
ToppCell	367C-Fibroblasts-Fibroblast-K_(Pericytes)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	PDE3A MYH11 SPEG BRSK2 F10 PTK2 MOCS1	2.32e-05	196	192	7	2f76f050083483f0880639e6c34ff349caac3503
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A MYH11 SPEG AFF3 TBX18 NALCN MICAL2	2.32e-05	196	192	7	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDE3A MYH10 MYH11 SPEG BRSK2 F10 MOCS1	2.32e-05	196	192	7	208ddedd29e1b9ca89cbb9b527c2e193a44cada2
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C PDE3A MYH11 SPEG TBX18 FRMD4A MOCS1	2.39e-05	197	192	7	cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C PDE3A MYH10 MYH11 MARK1 NALCN MOCS1	2.39e-05	197	192	7	6d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C PDE3A MYH10 MYH11 MARK1 SPEG MICAL3	2.39e-05	197	192	7	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	distal-mesenchymal-Vascular_Smooth_Muscle-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MYH11 SPTB MYO1B APOB F10 PTK2 MOCS1	2.39e-05	197	192	7	da653dc7d216e202f390e5ab0245f243e3ed213b
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1C ADAM23 AFF3 FRMD4A KCNC2 MICAL2 SCN8A	2.47e-05	198	192	7	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1C ADAM23 AFF3 FRMD4A KCNC2 MICAL2 SCN8A	2.47e-05	198	192	7	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1C MYH10 ADAM23 AFF3 FRMD4A MICAL2 SCN8A	2.47e-05	198	192	7	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	cellseq-Mesenchymal-Myocytic-Myocytic_2-VSMC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C PDE3A MYH10 MYH11 SPEG BRSK2 F10	2.47e-05	198	192	7	e967c601101361fc1c48dab0e5b76dc68813276e
ToppCell	Skin-Mesangial\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	PDE3A MYH10 MYH11 SPEG KCNC3 PRKAR1B DDX60L	2.55e-05	199	192	7	bcb78838a91cc7828680fb413fbacdb091c5fac0
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABL2 FRMD4A ABHD5 ALPK3 DDX60L TNNI2 GAA	2.55e-05	199	192	7	fde8e3ba19d19069a4d3b8db55bfe6220cf634d5
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C PDE3A MYH10 MYH11 MARK1 SPEG MICAL3	2.55e-05	199	192	7	b1753474152b82a0b811b9878c890a359e14919a
ToppCell	Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C PDE3A MYH11 SPTB F10 PTK2 MOCS1	2.55e-05	199	192	7	78a9b26215874a46a910a4b93a51fcac1a597618
ToppCell	Bronchial-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C PDE3A MYH11 MARK1 SPTB FRMD4A MOCS1	2.55e-05	199	192	7	854628ce91068093c14bd4d45ba38c41469f3549
ToppCell	Sigmoid-T_cell-Th1\|T_cell / Region, Cell class and subclass	ZC3H12A ABL2 ADAM23 OAS3 DBT BDH1 CD40LG	2.64e-05	200	192	7	bc9433a8ec3a6f10816730a32b821c63d78e6e87
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TAMALIN PTK2 PRX MACF1 CTNND1 DOCK6 RGL2	2.64e-05	200	192	7	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 OAS3 FRYL YTHDC1 ANKRD11 MACF1 DDX60L	2.64e-05	200	192	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	ZC3H12A RHBDF1 ITGA10 MYO1B LPIN3 TBX18 DOCK6	2.64e-05	200	192	7	a6f0f5f644b7262878b0b9d4d90ee407c4124dd9
ToppCell	distal-1-mesenchymal-Pericyte\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CACNA1C MYH11 FOXQ1 GAS6 PCDHA2 F10 MOCS1	2.64e-05	200	192	7	ff205afda57b9267016f0c937445da1b0266af9b
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TAMALIN PTK2 PRX MACF1 CTNND1 DOCK6 RGL2	2.64e-05	200	192	7	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	EPHB3 LARGE2 CACNA1F ME1 MYH14 SLC6A20 TJP3	2.64e-05	200	192	7	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C PDE3A MYH10 MYH11 MARK1 SPEG MICAL3	2.64e-05	200	192	7	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	ZC3H12A RHBDF1 ITGA10 MYO1B LPIN3 TBX18 DOCK6	2.64e-05	200	192	7	aafe594c88710f8c53d59667cdac5035e08f5511
ToppCell	distal-3-mesenchymal-Airway_Smooth_Muscle\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PDE3A MYH10 MYH11 SPEG F10 PTK2 MOCS1	2.64e-05	200	192	7	4072cfb3047954f507289587b4bfaf1526936992
ToppCell	distal-mesenchymal-Airway_Smooth_Muscle-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PDE3A MYH10 MYH11 SPEG BRSK2 F10 MOCS1	2.64e-05	200	192	7	c69173892d80b8592233928cb207a3f4b533b4b4
ToppCell	Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CPEB2 PDE3A MYH11 MARK1 MYO1B GTPBP2	3.39e-05	141	192	6	dcc56aef1b31bfe0de84cb0b5c77d242681cf19c
ToppCell	Pericytes-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	CACNA1C PDE3A MYH10 MYH11 SPEG MICAL2	4.80e-05	150	192	6	dbc202bd6db4fb5c8b2abd1200e074a2a9e63a59
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CPEB2 ME2 NCAPG2 F10 BAZ1A RRP12	6.40e-05	158	192	6	f61ebe3a316e4259387cd9da83707f15e6473cae
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	DCAF15 VLDLR EP400 MFSD9 DBT NOD1 ALMS1 TULP4 MICAL2 MACF1 MICAL3	7.10e-07	191	192	11	4168_DN
Drug	ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A	DNAH3 ADAM23 MARK1 SPEG MYO1B ARNT GRK3 SLC6A20 ALPK3 DOCK6 TJP3	1.07e-06	199	192	11	5931_UP
Drug	mepanipyrim	TGOLN2 TG NRK	5.83e-06	5	192	3	CID000086296
Drug	monastrol; Down 200; 100uM; MCF7; HG-U133A	DRG2 GAS6 ITGA10 BTBD2 DBT VAC14 RRP12 CTNND1 HTT TJP3	6.47e-06	195	192	10	681_DN
Drug	Propafenone hydrochloride [34183-22-7]; Up 200; 10.6uM; MCF7; HT_HG-U133A	TBKBP1 ADAM23 SPEG SPTB GAS6 MYO1B UBTD1 NOD1 MYH14 MICAL2	6.77e-06	196	192	10	2871_UP
Drug	Mercuric Chloride	THOC1 A1BG DNAJB11 RBM15 FOXQ1 PSMC3 APOB VPS36 DPP3 BTBD2 DBT ME1 F10 TG GSTP1 SH3PXD2B TULP4 BAZ1A RRP12 PUS1 MACF1 MICAL3 CTNND1 EIF3M TJP3	1.48e-05	1155	192	25	ctd:D008627
Disease	1,5 anhydroglucitol measurement	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	4.54e-10	29	184	7	EFO_0008009
Disease	visceral adipose tissue measurement, body mass index	PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2 SIK3	7.53e-08	87	184	8	EFO_0004340, EFO_0004765
Disease	lipid measurement, lipoprotein measurement	ABCA1 TBKBP1 GAS6 APOB SIK3 DOCK6	2.19e-05	90	184	6	EFO_0004529, EFO_0004732
Disease	level of Triacylglycerol (51:3) in blood serum	GATAD2A APOB SIK3	2.77e-05	10	184	3	OBA_2045163
Disease	Hypertrophic Cardiomyopathy	CACNA1C ATAD3A ALPK3 GAA MYBPC3	2.87e-05	57	184	5	C0007194
Disease	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	TAF13 HTT	3.87e-05	2	184	2	C4479476
Disease	red blood cell density measurement	CACNA1C VLDLR EP400 RRM2B AFF3 GAS6 ARFGEF2 SIK3 ZFYVE1 ME3 TG FRMD4A VAC14 BAZ1A PUS1 TJP2 PRKAR1B	3.99e-05	880	184	17	EFO_0007978
Disease	Charcot-Marie-Tooth disease type 4	SH3TC2 PRX MTMR2	6.52e-05	13	184	3	cv:C4082197
Disease	neutrophil count, basophil count	HECTD4 PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	8.66e-05	224	184	8	EFO_0004833, EFO_0005090
Disease	phospholipids:total lipids ratio	ABCA1 APOB SIK3 PRKAR1A MACF1 PISD DOCK6 MYBPC3	9.50e-05	227	184	8	EFO_0020946
Disease	vital capacity	THOC1 EPHB3 SH3TC2 PDE3A POLR2B AFF3 ARFGEF2 PCDHA13 PCDHA12 PCDHA8 PCDHA5 C16orf96 PCDHA4 PCDHA3 PCDHA2 APOB TBX18 TULP4 MICAL3 DCAF7	9.74e-05	1236	184	20	EFO_0004312
Disease	obsolete_red blood cell distribution width	ZC3H12A TBKBP1 CARMIL2 GATAD2A EP400 SPTB UBE3B GAS6 HECTD4 APOB SIK3 ZFYVE1 PTK2 ME3 FRMD4A CDH24 VPS13A MTMR2 PUS1 RP1 DOCK6	1.09e-04	1347	184	21	EFO_0005192
Disease	serine/threonine-protein kinase BRSK2 measurement	BRSK2 BRSK1	1.16e-04	3	184	2	EFO_0803063
Disease	Intellectual Disability	RRM2B APC2 AFF3 BRSK2 TH GTPBP2 SCN8A PUS1 MACF1 PISD HTT	1.24e-04	447	184	11	C3714756
Disease	post-traumatic stress disorder symptom measurement	PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	1.65e-04	82	184	5	EFO_0008535
Disease	polyunsaturated fatty acid measurement	ABCA1 TBKBP1 GAS6 APOB SIK3 DOCK6	1.78e-04	131	184	6	EFO_0010733
Disease	Sheldon-Hall syndrome	NALCN TNNI2	2.30e-04	4	184	2	cv:C1834523
Disease	Timothy syndrome (implicated_via_orthology)	CACNA1C CACNA1F	2.30e-04	4	184	2	DOID:0060173 (implicated_via_orthology)
Disease	Sotos' syndrome	APC2 NRK	2.30e-04	4	184	2	C0175695
Disease	neuroticism measurement, cognitive function measurement	CACNA1C PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2 FCHO1 TG VAC14 MTMR2	2.44e-04	566	184	12	EFO_0007660, EFO_0008354
Disease	apolipoprotein B measurement	VLDLR TBKBP1 CENPA GAS6 APOB SIK3 PTK2 PISD RP1 TAF13 DOCK6 ASAH2B HTT	2.86e-04	663	184	13	EFO_0004615
Disease	Cerebellar Hypoplasia	VLDLR ATAD3A	3.82e-04	5	184	2	C0266470
Disease	phospholipids in medium HDL measurement	ABCA1 APOB SIK3 DOCK6	3.89e-04	55	184	4	EFO_0022295
Disease	triglycerides in LDL measurement	ABCA1 GAS6 APOB SIK3	4.17e-04	56	184	4	EFO_0022320
Disease	cholesterol to total lipids in large LDL percentage	ABCA1 APOB SIK3 MYBPC3	4.17e-04	56	184	4	EFO_0022235
Disease	neutrophil count	VLDLR DCPS HECTD4 PCDHA13 PCDHA12 PCDHA8 MYO1B PCDHA5 PCDHA4 PCDHA3 PCDHA2 SIK3 FCHO1 TGOLN2 MICAL2 RRP12 ANKRD11 RP1 DOCK6 HTT	4.19e-04	1382	184	20	EFO_0004833
Disease	triglyceride measurement, alcohol consumption measurement	ABCA1 GAS6 APOB ASAH2B MYBPC3	4.36e-04	101	184	5	EFO_0004530, EFO_0007878
Disease	Charcot-Marie-Tooth disease (implicated_via_orthology)	FGD2 MTMR1 MTMR2	4.38e-04	24	184	3	DOID:10595 (implicated_via_orthology)
Disease	total lipids in medium HDL measurement	ABCA1 APOB SIK3 DOCK6	4.77e-04	58	184	4	EFO_0022310
Disease	free cholesterol in medium HDL measurement	ABCA1 APOB SIK3 DOCK6	4.77e-04	58	184	4	EFO_0022267
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	ABCA1 GATAD2A APOB SIK3 MACF1 DOCK6 HTT MYBPC3	5.09e-04	291	184	8	EFO_0008317, EFO_0020946
Disease	cholesterol in medium HDL measurement	ABCA1 APOB SIK3 DOCK6	5.10e-04	59	184	4	EFO_0021903
Disease	Acidosis, Lactic	RRM2B ATAD3A	5.71e-04	6	184	2	C0001125
Disease	Digitotalar Dysmorphism	NALCN TNNI2	5.71e-04	6	184	2	C1852085
Disease	ARTHROGRYPOSIS, DISTAL, TYPE 1	NALCN TNNI2	5.71e-04	6	184	2	C0220662
Disease	ARTHROGRYPOSIS, DISTAL, TYPE 2B	NALCN TNNI2	5.71e-04	6	184	2	C1834523
Disease	free cholesterol in HDL measurement	ABCA1 APOB SIK3 DOCK6	5.79e-04	61	184	4	EFO_0022264
Disease	phospholipids in HDL measurement	ABCA1 APOB SIK3 DOCK6	5.79e-04	61	184	4	EFO_0022293
Disease	triglycerides in medium LDL measurement	ABCA1 GAS6 APOB SIK3	6.16e-04	62	184	4	EFO_0022322
Disease	total lipids in HDL measurement	ABCA1 APOB SIK3 DOCK6	6.54e-04	63	184	4	EFO_0022307
Disease	triglycerides in small LDL measurement	ABCA1 GAS6 APOB SIK3	7.36e-04	65	184	4	EFO_0022323
Disease	antihyperlipidemic drug use measurement	ABCA1 DCPS GAS6 APOB RP1	7.88e-04	115	184	5	EFO_0803367
Disease	heroin dependence	MYH10 BRSK2	7.96e-04	7	184	2	EFO_0004240
Disease	alcohol consumption measurement	ENTPD7 CACNA1C MYH10 CABP5 UBE3B AFF3 PSMC3 DPP3 FRMD4A ALMS1 KCNC2 SCN8A ANKRD11 UQCRQ MICAL3 CLEC16A HTT MYBPC3	8.06e-04	1242	184	18	EFO_0007878
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	ABCA1 APOB SIK3 MACF1	8.26e-04	67	184	4	EFO_0008595, EFO_0020946
Disease	sleep duration, high density lipoprotein cholesterol measurement	ABCA1 CARMIL2 APOB MACF1 DOCK6	9.90e-04	121	184	5	EFO_0004612, EFO_0005271
Disease	Sudden Cardiac Death	CACNA1C MYBPC3	1.06e-03	8	184	2	C0085298
Disease	linoleic acid measurement	ABCA1 FGD2 GAS6 APOB SIK3 DOCK6	1.14e-03	186	184	6	EFO_0006807
Disease	esterified cholesterol measurement	ABCA1 TBKBP1 APOB SIK3 DOCK6	1.27e-03	128	184	5	EFO_0008589
Disease	very low density lipoprotein cholesterol measurement	ABCA1 TBKBP1 GAS6 APOB SIK3 TAF13 ASAH2B	1.28e-03	260	184	7	EFO_0008317
Disease	triacylglycerol 52:5 measurement	GATAD2A SIK3 TG	1.35e-03	35	184	3	EFO_0010417
Disease	Distal arthrogryposis	NALCN TNNI2	1.35e-03	9	184	2	cv:C0265213
Disease	familial hypertrophic cardiomyopathy (is_implicated_in)	ALPK3 MYBPC3	1.35e-03	9	184	2	DOID:0080326 (is_implicated_in)
Disease	centronuclear myopathy X-linked (implicated_via_orthology)	MTMR1 MTMR2	1.35e-03	9	184	2	DOID:0111225 (implicated_via_orthology)
Disease	triacylglycerol 52:4 measurement	GATAD2A APOB SIK3	1.46e-03	36	184	3	EFO_0010416
Disease	omega-6 polyunsaturated fatty acid measurement	ABCA1 TBKBP1 GAS6 APOB SIK3 DOCK6	1.53e-03	197	184	6	EFO_0005680
Disease	retinal vasculature measurement	DHX16 GIPC1 LARGE2 CACNA1C PDE3A AFF3 FBXO46 ABHD5 TJP2 MOCS1	1.59e-03	517	184	10	EFO_0010554
Disease	cholesterol in large HDL measurement	ABCA1 APOB SIK3 DOCK6	1.60e-03	80	184	4	EFO_0021900
Disease	complex trait	ABCA1 GATAD2A CENPA APOB SIK3 SLC5A11 MACF1	1.62e-03	271	184	7	EFO_0010578
Disease	cardiovascular system disease (is_marker_for)	APOB CD40LG	1.68e-03	10	184	2	DOID:1287 (is_marker_for)
Disease	uremia (biomarker_via_orthology)	PTK2 TH	1.68e-03	10	184	2	DOID:4676 (biomarker_via_orthology)
Disease	level of Ceramide (d42:1) in blood serum	GATAD2A SIK3	1.68e-03	10	184	2	OBA_2045187
Disease	nephritis (implicated_via_orthology)	CYP2J2 PTK2	1.68e-03	10	184	2	DOID:10952 (implicated_via_orthology)
Disease	post-traumatic stress disorder	AFF3 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2	1.73e-03	202	184	6	EFO_0001358
Disease	Graves' disease (is_implicated_in)	TG GSTP1 CD40LG	1.85e-03	39	184	3	DOID:12361 (is_implicated_in)
Disease	sphingomyelin measurement	ABCA1 TBKBP1 APOB SIK3 SCN8A ANKRD11 DOCK6	1.87e-03	278	184	7	EFO_0010118
Disease	autosomal dominant nonsyndromic deafness (is_implicated_in)	THOC1 PI4KB	2.05e-03	11	184	2	DOID:0050564 (is_implicated_in)
Disease	N-acetylphenylalanine measurement	GSTP1 ALMS1	2.05e-03	11	184	2	EFO_0800019
Disease	level of Diacylglycerol (18:1_18:1) in blood serum	APOB SIK3	2.05e-03	11	184	2	OBA_2045170
Disease	phosphatidylcholine measurement	ABCA1 GATAD2A APOB PTK2 MACF1 PRKCQ DOCK6	2.11e-03	284	184	7	EFO_0010226
Disease	total blood protein measurement	DNAH3 AFF3 MTMR1 RFX8 MACF1 MICAL3 CLEC16A ASAH2B ARAP1	2.13e-03	449	184	9	EFO_0004536
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	ABCA1 GATAD2A APOB SIK3 MACF1	2.14e-03	144	184	5	EFO_0004611, EFO_0020943
Disease	Charcot-Marie-Tooth disease	SH3TC2 PRX MTMR2	2.29e-03	42	184	3	cv:C0007959
Disease	N-delta-acetylornithine measurement	ALMS1 FBXO41	2.45e-03	12	184	2	EFO_0800067
Disease	dementia (is_implicated_in)	VLDLR VCP	2.45e-03	12	184	2	DOID:1307 (is_implicated_in)
Disease	alcohol consumption measurement, alcohol drinking	HECTD4 OAS3	2.45e-03	12	184	2	EFO_0004329, EFO_0007878
Disease	triglycerides in large LDL measurement	ABCA1 APOB SIK3	2.45e-03	43	184	3	EFO_0022319
Disease	Seizures	RRM2B APC2 AFF3 DBT GTPBP2 MACF1	2.54e-03	218	184	6	C0036572
Disease	reticulocyte measurement	ABCA1 GATAD2A SPTB AFF3 HECTD4 ARFGEF2 MYO1B F10 NOD1 BAZ1A MICAL2 VPS13A PRKAR1A CTNND1 GAA	2.59e-03	1053	184	15	EFO_0010700
Disease	platelet crit	CACNA1C VLDLR DNAH3 GATAD2A AFF3 APOB BTBD2 NCAPG2 LPIN3 TULP4 MYLK4 CD40LG RP1 GAA	2.69e-03	952	184	14	EFO_0007985
Disease	Gastric Adenocarcinoma	MARK1 SPEG BRSK1	2.79e-03	45	184	3	C0278701
Disease	saturated fatty acids measurement	ABCA1 APOB SIK3	2.79e-03	45	184	3	EFO_0022304
Disease	pulse pressure measurement	PDE3A MYH11 GATAD2A PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2 FRYL SLC5A11 TBX18 VAC14 ANKRD11 CTNND1 CLEC16A MYBPC3	2.82e-03	1392	184	18	EFO_0005763
Disease	pre-eclampsia (implicated_via_orthology)	CYP2J2 CD40LG	2.88e-03	13	184	2	DOID:10591 (implicated_via_orthology)
Disease	Hyperlipoproteinemia Type IIb	ABCA1 APOB	2.88e-03	13	184	2	C1704417
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	ABCA1 GAS6 APOB MACF1 TAF13 ASAH2B	2.90e-03	224	184	6	EFO_0004530, EFO_0008317
Disease	disorder of pharynx	CARMIL2 ADAM23 ARNT	2.97e-03	46	184	3	MONDO_0020592
Disease	Thrombus	PDE3A GAS6 F10	2.97e-03	46	184	3	C0087086
Disease	schizophrenia, anorexia nervosa	CACNA1C GATAD2A ALMS1	3.36e-03	48	184	3	MONDO_0005090, MONDO_0005351
Disease	total lipids in lipoprotein particles measurement	ABCA1 APOB DOCK6	3.36e-03	48	184	3	EFO_0022309
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	ABCA1 GAS6 APOB RP1	3.48e-03	99	184	4	EFO_0004611, EFO_0007878
Disease	Abnormality of refraction	PDE3A CABP5 PCDHA13 PCDHA12 PCDHA8 PCDHA5 PCDHA4 PCDHA3 PCDHA2 NOD1 TJP2	3.48e-03	673	184	11	HP_0000539
Disease	Thrombosis	PDE3A GAS6 F10	3.56e-03	49	184	3	C0040053
Disease	ceramide measurement	ABCA1 GATAD2A RRM2B APOB MICAL2 PRKCQ	3.67e-03	235	184	6	EFO_0010222
Disease	cholesteryl esters to total lipids in IDL percentage	APOB SIK3 MACF1	3.77e-03	50	184	3	EFO_0022247
Disease	triacylglycerol 52:3 measurement	APOB SIK3	3.85e-03	15	184	2	EFO_0010415
Disease	N-acetylmethionine measurement	ALMS1 MICAL2	3.85e-03	15	184	2	EFO_0021427
Disease	response to peritoneal dialysis, peritoneal solute transfer rate	KCNC2 BAZ1A	3.85e-03	15	184	2	EFO_0600089, EFO_0600090
Disease	low density lipoprotein cholesterol measurement, alcohol drinking	ABCA1 GAS6 APOB RP1	3.87e-03	102	184	4	EFO_0004329, EFO_0004611
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	ABCA1 TBKBP1 GAS6 APOB ASAH2B	3.93e-03	166	184	5	EFO_0004530, EFO_0004611

Protein segments in the cluster

Peptide	Gene	Start	Entry
RTRGLSRIVPKSKEF	AFF3	651	P51826
KVDKVLLGARRRPFR	MAMDC4	601	Q6UXC1
IVQRAIKRRPGLDFD	ARNT	36	P27540
SLFDRATPGLLKIRR	EP400	2316	Q96L91
LFRGRVIKVLPKRTN	PABPN1L	211	A6NDY0
LEIKPAPFVRSRFKR	BDP1	1426	A6H8Y1
FKEAQRLLRRAPKFL	GRK3	651	P35626
LKRRKRAVNPSRGIF	ADAM23	281	O75077
VRERASKRKLPFTAG	ANKRD11	51	Q6UB99
KSPGRFERILLRAAN	CD40LG	196	P29965
VAFLLAADFLKRRRP	CYP2J2	26	P51589
FFTPRLIKKTLGLRA	ABL2	751	P42684
TKSFLPLIRRAKGRV	BDH1	176	Q02338
RRLFPVDRGLFEDKV	ALG6	261	Q9Y672
KKVFPRSTLGKLFRR	CARMIL2	116	Q6F5E8
RFIEARLGKPSLVRE	ATAD3A	321	Q9NVI7
LLLRIVDRAPKGRTF	ASAH2B	26	P0C7U1
KLRTGEKAVVRFRFL	GTPBP2	546	Q9BX10
GLPREKLAAAERVLR	ABCA1	216	O95477
LRAVLRKFFLRIGVV	ARFGEF2	1751	Q9Y6D5
PDFISRSGERIKRLK	ALMS1	4046	Q8TCU4
ATPEELALGARRKRF	ALPK3	1356	Q96L96
LALGARRKRFLPKVR	ALPK3	1361	Q96L96
LAGLRSRRLKQPKAF	MIR22HG	36	Q0VDD5
ARVDAKSRVLFPLGL	COQ6	336	Q9Y2Z9
RLLKELPRGRTFTLK	GIPC1	196	O14908
KFDRRRPFIEQVGLV	AQR	576	O60306
ILFGLIKDVARFRPE	DHX16	531	O60231
RLPFSGFRLQKVLRE	DCPS	41	Q96C86
VRPDKRFRLALGSFV	DCAF7	26	P61962
DVFVELLSPRRKRRG	BAZ1A	1346	Q9NRL2
LSKVAAFRAKGRVPV	MTMR1	276	Q13613
RFGVITEVDIKRPSR	RBM15	396	Q96T37
FTKGIPNVLRRIRES	UQCRQ	31	O14949
GKIIREIFPDIKARR	RFX5	136	P48382
VVGRARLPALKDRAA	CYP2F1	331	P24903
RRKAALVVPAFETLR	LARGE2	546	Q8N3Y3
LEELVPRLFRVASKR	PCDHA2	56	Q9Y5H9
FQLRRGEKELLVPRS	A1BG	241	P04217
REELKPIAFARGIKL	DBT	291	P11182
VIKPRRKLAFRSGEA	GATAD2A	501	Q86YP4
DVKALRAFRVLRPLR	CACNA1F	201	O60840
AKAFRLPGLSRRERE	FCHO1	286	O14526
RFGKLGVLRSREKVV	LPIN3	51	Q9BQK8
LAELVPRLFRVASKR	PCDHA8	56	Q9Y5H6
LAELVPRLFRVASKR	PCDHA3	56	Q9Y5H8
KDVLGFLRVVRFVRI	KCNC2	341	Q96PR1
VKLFVREPEKRLGVR	PRKCQ	611	Q04759
GFRRKEFRGKLAIAI	MICAL3	231	Q7RTP6
VFRKPRGLFITIHDR	ME1	116	P48163
ERFALKILLDRPKAR	MAPKAPK5	46	Q8IW41
RSPLARQLFRIEGVK	NFU1	96	Q9UMS0
KTRFLPLRDLRQEGV	ENTPD7	521	Q9NQZ7
FVLALEERFGVRPKV	MFSD9	306	Q8NBP5
IAPKGRELVVFFSLR	IMPG1	566	Q17R60
VKFREGERPSLRLQL	EIF3M	91	Q7L2H7
GRLTPKEARKFFRQI	BRSK2	111	Q8IWQ3
LERVLPRVRFTRHGK	DDX60L	1221	Q5H9U9
FLRKGIAEKQRERPL	CABP5	11	Q9NP86
RRGPFKDVASVRVAV	CDH24	351	Q86UP0
FSRALLTPRIKVGRD	MYH14	411	Q7Z406
FLEIRFKIQRLLEPR	FBXO46	456	Q6PJ61
IAGTKEDIPVFKRRR	PDE3A	276	Q14432
VKFISRGRRPDVILE	KAT14	291	Q9H8E8
IVRQAKRDRGLPLFD	KAT14	496	Q9H8E8
REIRALFALLEIPKG	FRYL	711	O94915
IDFGLARRYKPREKL	MYLK4	246	Q86YV6
TARTGIEVPRQFLRK	NOD1	331	Q9Y239
KRVASFRSRGRIPVL	MTMR2	256	Q13614
RSVGKPALERFLRRL	DPP3	611	Q9NY33
RLKQPGRREVFVAIK	EPHB3	651	P54753
LQLRAPLKTRDREFG	GARIN5A	211	Q6IPT2
RFLGGVFSKRRIPKR	PRDM10	216	Q9NQV6
LFTVRSEKLRRAPGE	NUDT7	56	P0C024
AELVPRLFRVASKGR	PCDHA5	56	Q9Y5H7
ARPIKGFAVVEIRSR	HECTD4	3161	Q9Y4D8
VRLKPTRKFALLGRQ	RPL13AP3	41	Q6NVV1
RSFRRRLLKFIPGLN	TAMALIN	371	Q7Z6J2
RGRTNIELREKFILP	MACF1	7191	Q9UPN3
TLVPAKFEFIVRRKG	MOCS1	181	Q9NZB8
LAELVPRLFRVASKR	PCDHA13	56	Q9Y5I0
LAELVPRLFRVASKG	PCDHA4	56	Q9UN74
FFMGRLVKRIPESRI	PLA2G4E	556	Q3MJ16
SVRKGKALVARLLPF	PATL2	366	C9JE40
FRRRVTDPSLIFKQL	OSGIN2	331	Q9Y236
KNRRRVFGLLERPVL	CPLANE2	31	Q9BU20
PIVRRRIGTAFKLDE	FRMD4A	436	Q9P2Q2
LKVRFPLRLTGKIDF	APOB	3056	P04114
FRRQLTFIKESPGLR	APC2	1991	O95996
ERVSVLFDRIRKGFP	HTT	2956	P42858
FDVKALRAFRVLRPL	CACNA1C	231	Q13936
RKLRFPGRFLDDITA	DOCK6	956	Q96HP0
RIERFSRKVFVGGLP	CPEB2	326	Q7Z5Q1
IERARGFLERKLPDI	C3P1	286	Q6ZMU1
PDSAAGFRRKLFKRV	C16orf96	896	A6NNT2
RFVRTAEILAGKLPL	DNAH3	366	Q8TD57
LERLRIAKVTGVAFP	EFCAB10	46	A6NFE3
LFPKDVQLARRIRGL	CENPA	121	P49450
FSGTPVIRLRFKRLQ	GAS6	301	Q14393
VGRLSARPKLKAFLA	GSTP1	181	P09211
GRLTPKEARKFFRQI	BRSK1	126	Q8TDC3
FRIKVVKHPIFERRG	DNAJB11	241	Q9UBS4
ALVKARGTRPFVISR	GAA	586	P10253
VTKLQALRRRPGFSK	FBXO41	851	Q8TF61
KLPRLSLNGVRFKRI	MARK1	761	Q9P0L2
IFRRPKGLFISISDR	ME2	126	P23368
TFRRPRGLFITIHDK	ME3	151	Q16798
TFLRRLVGKLFIDPE	ITGA10	186	O75578
RKAPFVVRGGRRKVL	ITGA10	811	O75578
LREGPVLKISFRRND	FGD2	321	Q7Z6J4
KCVKLDRPRFERVLG	PRKAR1A	346	P10644
KCVKLDRPRFERVLG	PRKAR1B	346	P31321
RLPAFKRKTLVLIGA	MPP1	276	Q00013
FDIAVLRLKTPITFR	F10	321	P00742
RRKVLGKALGLIRFP	BTBD2	306	Q9BX70
KGISLRFPRFIRVRE	LIG1	866	P18858
GEFKALTRRLQVEPR	POLRMT	151	O00411
DGVPALVRLLRKARD	CTNND1	451	O60716
ERVKISGQLSPRLFR	DCAF15	41	Q66K64
EFTRAILTPRIKVGR	MYH10	391	P35580
FAIDSILRKPFRSRR	FOXQ1	271	Q9C009
GFRRKEFRGKLAIAI	MICAL2	231	O94851
AFKLLLARKSRPRGF	MLNR	366	O43193
LVTIFRIPSVAGRRK	OR10C1	221	Q96KK4
LAELVPRLFRVASKR	PCDHA12	56	Q9UN75
IVRRFERKGFKLVAL	NME3	41	Q13232
LDRFVARRLQPRKEF	OAS3	11	Q9Y6K5
PRKEFVEKARRALGA	OAS3	21	Q9Y6K5
LVVFRNGDPKTRRAV	RP1	156	P56715
SGKADITKLIRRRPF	NRK	1236	Q7Z2Y5
KRFSSERKLLEVRGP	VAC14	536	Q08AM6
SFPRIKATGRKIARA	RGL2	761	O15211
TGIVKKFPRFRNREL	SEL1L3	261	Q68CR1
PFLSVFKKGRRRVPV	PLEKHN1	76	Q494U1
PFVREGLEFAVIRVK	PUS1	271	Q9Y606
RFLKPDVRLSRGSID	PTK2	831	Q05397
GLNVPRSKRLFRDLV	PPP1R35	151	Q8TAP8
RILREVREPKRIFFG	PRAMEF22	441	A3QJZ6
RRGQRIAVPVRKLFA	RHBDF1	351	Q96CC6
IAVPVRKLFAREKRP	RHBDF1	356	Q96CC6
VFVLKRRKGVPSVPR	SLITRK2	641	Q9H156
IRVRSVRIPQIGDKF	POLR2B	921	P30876
LRARVLSGKFRIPFF	SIK3	271	Q9Y2K2
RINKIPFGIFSRAKV	SHOC2	366	Q9UQ13
YLRKRFGGIRIPIIL	SLC5A11	131	Q8WWX8
GAVPLARRLKAVRTE	SH3TC2	1111	Q8TF17
LFKFLRSLLDPREGI	VPS8	1001	Q8N3P4
IVFLIRKDPRKFARV	TAF13	86	Q15543
LIDAVGFSPLRILRK	SLC26A3	556	P40879
GFSPLRILRKRNKAL	SLC26A3	561	P40879
KRGQRPDFTDAIILR	DRG2	296	P55039
KEPVFIAAGDIRRRL	PI4KB	496	Q9UBF8
PLAALGTFVQRRLKR	SLC6A20	571	Q9NP91
FIRKFGFELVKRLLP	RRP12	1011	Q5JTH9
IAAAKELFPRRRTGF	SPICE1	116	Q8N0Z3
GLSLVQRLRPDFKRK	ABHD5	221	Q8WTS1
LKRFLRDLPDGLFTR	ARAP1	1031	Q96P48
ARSFRKQPEEGLRLL	NCAPG2	966	Q86XI2
FVKRLPCGDVEKTRR	CLEC16A	651	Q2KHT3
DFTRSILTPRIKVGR	MYH11	391	P35749
EEPLLRKSSRRFVIF	RRM2B	31	Q7LG56
FDLRGKFKRPPLRRV	TNNI2	101	P48788
AFVLEGKRSKVTRRP	TGOLN2	411	O43493
ILKGRRISKLRPEFV	TULP4	471	Q9NRJ4
RVLLREAGFKRPVVL	TJP2	721	Q9UDY2
RLSEFIPAVFRLKDR	WASHC5	31	Q12768
FTKEPFIVHGRRLRI	VPS13A	3116	Q96RL7
KILVFTPSRRVGGKR	ZC3H12A	206	Q5D1E8
ALKLPLRLRVFDSGV	VPS36	296	Q86VN1
RERFIPFSKEQLLRL	TMEM143	71	Q96AN5
KFKRSRESPLSLGLR	SPEG	2336	Q15772
EAYRPIRKGDIFLVR	VCP	141	P55072
RLKIDRNPFAKGFRD	TBX18	316	O95935
LPGKILFRRSHIRDV	SH3PXD2B	76	A1X283
KLVRLVFPDLGTRRL	RFX8	66	Q6ZV50
SEFFRRKLKPQARPV	PISD	166	Q9UG56
PKFSRLRRGLKAEAV	PRX	161	Q9BXM0
ALLRSGRLDRKIEFP	PSMC3	341	P17980
RKAFRLPDNRIGRKF	SCN8A	526	Q9UQD0
LLKRSRIPIFKADRP	SERPINE3	366	A8MV23
FLKGDRNIIRISSRP	TECPR2	341	O15040
IEKRFLDLLEPLGRR	SPTB	1456	P11277
RGKRLGILVVFSFIK	TEX261	171	Q6UWH6
RREFPLKVRLSTGKD	UBTD1	146	Q9HAC8
RKRARGISPIVFDRS	YTHDC1	301	Q96MU7
PEKLIQDRFRKLGRF	ZFYVE1	336	Q9HBF4
VLREASFKRPVVILG	TJP3	611	O95049
LGSVLRGFFTIRKRE	UBE3B	1011	Q7Z3V4
LFRKPQRSFFGKLLR	SLC30A6	6	Q6NXT4
RRAFEGIRLRFEKQP	TBKBP1	506	A7MCY6
KEAIRAIFPSRGLAR	TG	441	P01266
RIIRKRTAPEDFLGK	THOC1	411	Q96FV9
VSRFLKERTGFQLRP	TH	306	P07101
PSLIFTNRRDIRKIG	VLDLR	441	P98155
AKDVLGFLRVVRFVR	KCNC3	406	Q14003
GRSKIFIRNPRTLFK	MYO1B	681	O43795
REGVIPTFRVKFLLR	NALCN	1481	Q8IZF0
PTFRVKFLLRLLRGR	NALCN	1486	Q8IZF0
VKDLPTGARLLFRVR	MYBPC3	931	Q14896